BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 35545323)

  • 21. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.
    Thourani VH; Kodali S; Makkar RR; Herrmann HC; Williams M; Babaliaros V; Smalling R; Lim S; Malaisrie SC; Kapadia S; Szeto WY; Greason KL; Kereiakes D; Ailawadi G; Whisenant BK; Devireddy C; Leipsic J; Hahn RT; Pibarot P; Weissman NJ; Jaber WA; Cohen DJ; Suri R; Tuzcu EM; Svensson LG; Webb JG; Moses JW; Mack MJ; Miller DC; Smith CR; Alu MC; Parvataneni R; D'Agostino RB; Leon MB
    Lancet; 2016 May; 387(10034):2218-25. PubMed ID: 27053442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis.
    Forrest JK; Ramlawi B; Deeb GM; Zahr F; Song HK; Kleiman NS; Chetcuti SJ; Michelena HI; Mangi AA; Skiles JA; Huang J; Popma JJ; Reardon MJ
    JAMA Cardiol; 2021 Jan; 6(1):50-57. PubMed ID: 33031491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement.
    Fischer Q; Himbert D; Bernier M; Urena M; Nunes Ferreira-Neto A; Paradis JM; Mohammadi S; Iung B; Rodés-Cabau J
    Int J Cardiol; 2019 Jul; 286():36-42. PubMed ID: 30967274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
    Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
    Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts.
    Szerlip M; Gualano S; Holper E; Squiers JJ; White JM; Doshi D; Williams MR; Hahn RT; Webb JG; Svensson LG; Kirtane AJ; Cohen DJ; Douglas PS; Alu MC; Crowley A; Tuzcu EM; Makkar RR; Herrmann HC; Babaliaros V; Thourani VH; Leon MB; Kodali SK; Mack MJ
    JACC Cardiovasc Interv; 2018 Jan; 11(1):13-20. PubMed ID: 29301644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
    Deeb GM; Reardon MJ; Chetcuti S; Patel HJ; Grossman PM; Yakubov SJ; Kleiman NS; Coselli JS; Gleason TG; Lee JS; Hermiller JB; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Maini B; Mumtaz M; Conte J; Resar J; Aharonian V; Pfeffer T; Oh JK; Qiao H; Adams DH; Popma JJ;
    J Am Coll Cardiol; 2016 Jun; 67(22):2565-74. PubMed ID: 27050187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
    Popma JJ; Deeb GM; Yakubov SJ; Mumtaz M; Gada H; O'Hair D; Bajwa T; Heiser JC; Merhi W; Kleiman NS; Askew J; Sorajja P; Rovin J; Chetcuti SJ; Adams DH; Teirstein PS; Zorn GL; Forrest JK; Tchétché D; Resar J; Walton A; Piazza N; Ramlawi B; Robinson N; Petrossian G; Gleason TG; Oh JK; Boulware MJ; Qiao H; Mugglin AS; Reardon MJ;
    N Engl J Med; 2019 May; 380(18):1706-1715. PubMed ID: 30883053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.
    Al-Khadra Y; Darmoch F; Baibars M; Kaki A; Fanari Z; Alraies MC
    J Interv Cardiol; 2018 Oct; 31(5):655-660. PubMed ID: 29774601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors and clinical outcomes of poor symptomatic improvement after transcatheter aortic valve replacement.
    Yoshijima N; Saito T; Inohara T; Anzai A; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34810275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
    Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F
    JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
    Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
    Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Goel S; Pasam RT; Wats K; Patel J; Chava S; Gotesman J; Malik BA; Frankel R; Shani J; Gidwani U
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):169-178. PubMed ID: 31631514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease.
    Chahine J; Kadri AN; Gajulapalli RD; Krishnaswamy A; Mick S; Perez O; Lak H; Nair RM; Montane B; Tak J; Tuzcu EM; Griffin B; Svensson LG; Harb SC; Kapadia SR
    JACC Cardiovasc Interv; 2019 Nov; 12(22):2299-2306. PubMed ID: 31678084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
    Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.